Back to Search
JOSHUA HOOD, DO
DO
Public Health & General Preventive Medicine Physician
NPI: 1457934317Individual
Specialties, Licenses & Credentials
Public Health & General Preventive Medicine PhysicianPrimary
Preventive Medicine — Public Health & General Preventive Medicine
Code: 2083P0901X
101442-851(WI)
Research & Publications (20)
Service-learning in dental education: meeting needs and challenges.
PMID 19339432·J Dent Educ·2009
6-review
Consumer involvement in the South Australian state policy for planned home birth.
PMID 19278387·Birth·2009
8-other
Jak2 inhibition deactivates Lyn kinase through the SET-PP2A-SHP1 pathway, causing apoptosis in drug-resistant cells from chronic myelogenous leukemia patients.
PMID 19234487·Oncogene·2009
7-preclinical
Efficacy of TG101348, a selective JAK2 inhibitor, in treatment of a murine model of JAK2V617F-induced polycythemia vera.
PMID 18394554·Cancer Cell·2008
7-preclinical
Comparison of the immunostimulatory and proinflammatory activities of candidate Gram-positive endotoxins, lipoteichoic acid, peptidoglycan, and lipopeptides, in murine and human cells.
PMID 18468694·Immunol Lett·2008
4-observational
Decreased differentiation of erythroid cells exacerbates ineffective erythropoiesis in beta-thalassemia.
PMID 18480424·Blood·2008
7-preclinical
Chronic sodium nitrite therapy augments ischemia-induced angiogenesis and arteriogenesis.
PMID 18508974·Proc Natl Acad Sci U S A·2008
7-preclinical
Fish distributions and nutrient cycling in streams: can fish create biogeochemical hotspots?
PMID 18724743·Ecology·2008
7-preclinical
Pertussis update--an occupational health perspective for the 21st century.
PMID 18293595·AAOHN J·2008
6-review
Topical administration of a multi-targeted kinase inhibitor suppresses choroidal neovascularization and retinal edema.
PMID 18330892·J Cell Physiol·2008
7-preclinical
Development of prodrug 4-chloro-3-(5-methyl-3-{[4-(2-pyrrolidin-1-ylethoxy)phenyl]amino}-1,2,4-benzotriazin-7-yl)phenyl benzoate (TG100801): a topically administered therapeutic candidate in clinical trials for the treatment of age-related macular degeneration.
PMID 18311895·J Med Chem·2008
7-preclinical
TG101348, a JAK2-selective antagonist, inhibits primary hematopoietic cells derived from myeloproliferative disorder patients with JAK2V617F, MPLW515K or JAK2 exon 12 mutations as well as mutation negative patients.
PMID 18354492·Leukemia·2008
8-other
Retinal vascular permeability suppression by topical application of a novel VEGFR2/Src kinase inhibitor in mice and rabbits.
PMID 18483622·J Clin Invest·2008
7-preclinical
The pregnant health care worker--an evidence-based approach to job assignment and reassignment.
PMID 18717297·AAOHN J·2008
6-review
Results of a multicentre randomised controlled trial of statistical process control charts and structured diagnostic tools to reduce ward-acquired meticillin-resistant Staphylococcus aureus: the CHART Project.
PMID 18723251·J Hosp Infect·2008
4-observational
Selective inhibition of JAK2-driven erythroid differentiation of polycythemia vera progenitors.
PMID 18394555·Cancer Cell·2008
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- UW HOSPITALS & CLINICS 600 HIGHLAND AVE
MADISON, WI 53792 - Phone
- (608) 263-6400
Quick Facts
- NPI
- 1457934317
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile